A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.

ABSTRACT:

SUBMITTER: Westritschnig K 

PROVIDER: S-EPMC4181012 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature